Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 97

Sort by

Sort Order Select

Journal Articles

Vaso-Occlusive Crises and Costs of Sickle Cell Disease from a Commercial Payer's Perspective

George J Joseph, Dominick Latremouille-Viau, Vikash Kumar Sharma, Patrick Gagnon-Sanschagrin, Menaka Bhor, PhD, Ankur Khare, Mukesh Kumar Singh, Elizabeth Serra, Mikhail Davidson, Annie Guerin, Nirmish Shah

Blood (2019) 134 (Supplement_1): 3464.

https://doi.org/10.1182/blood-2019-124920

Published: 2019

Journal Articles

A Standardized Clinical Flow Adhesion Assay of Whole Blood Adhesion to VCAM-1 Predicts Severe SCD Phenotypes in a 2-Yr Prospective Observational Follow-up of the Original Elipsis Cohort

Patrick C. Hines, MD PhD, Ahmar Urooj Zaidi, MD, Xiufeng Gao, MD, Ke Liu, PhD, Muhammad O. Shareef, Michael Callaghan, Jennell White, PhD

Blood (2019) 134 (Supplement_1): 3562.

https://doi.org/10.1182/blood-2019-126371

Published: 2019

Journal Articles

Hydroxyurea Therapy to Prevent Incident Stroke Among Children with Sickle Cell Anaemia in Jamaica: The Extend Trial

Angela Rankine-Mullings, MBBS, Marvin Ellsworth Reid, MB, BS, PhD, Deanne Soares, MBBS,DM Radiology, Carolyn Taylor-Bryan, MBBS, PhD BSc, DM, Margaret Wisdom-Phipps, RN, RM, Karen Aldred, MSc, Teresa Latham, MA, Jennifer Knight-Madden, MBBS, PhD, Lesley King, MBBS, MRCP, Asha Badaloo, PhD, Adam Lane, PhD, Robert J. Adams, MD MS, Russell E. Ware, MD PhD

Blood (2019) 134 (Supplement_1): 2269.

https://doi.org/10.1182/blood-2019-126781

Published: 2019

Journal Articles

Burden of Illness of Sickle Cell Disease in Countries of the Middle East: A Systematic Literature Review

Miranda Bailey, Megan Gibbs, Nidhi Dani, Ari Mendell, Melissa Thompson

Blood (2019) 134 (Supplement_1): 5867.

https://doi.org/10.1182/blood-2019-131699

Published: 2019

Journal Articles

Sickle Cell Disease Burden in North Lebanon

Adlette Inati, MD, Chadi Al Alam, Cristel El Ojaimi, Taghrid Hamad, Hemanth Kanakamedala, Virginia Pilipovic, Ramzieh Sabah

Blood (2019) 134 (Supplement_1): 1022.

https://doi.org/10.1182/blood-2019-128311

Published: 2019

Journal Articles

Characteristics of Marijuana Usage in Sickle Cell Patients: A Nationwide Analysis

Arya Mariam Roy, MD, Manojna Konda, MD, Akshay Goel, MD, Appalanaidu Sasapu, MD

Blood (2019) 134 (Supplement_1): 4848.

https://doi.org/10.1182/blood-2019-131489

Published: 2019

Journal Articles

Barriers and Facilitators to Chronic Red Cell Transfusion Therapy for Children with Sickle Cell Anemia: Results from the Displace Consortium

Alyssa M Schlenz, PhD, Shannon Phillips, PhD RN, Martina Mueller, PhD, Cathy Melvin, PhD MPH, Robert J. Adams, MD MS

Blood (2019) 134 (Supplement_1): 4697.

https://doi.org/10.1182/blood-2019-130646

Published: 2019

Journal Articles

Splenomegaly in Children with Sickle Cell Anemia Receiving Hydroxyurea in Sub-Saharan Africa

Leon Tshilolo, MD PhD, George A. Tomlinson, PhD BSc, MSc, Patrick T. McGann, MD, Teresa S. Latham, MA, Peter Olupot-Olupot, Brigida Santos, Banu Aygun, MD, Susan Stuber, MA, Adam Lane, PhD, Thomas N. Williams, Russell E. Ware, MD PhD

Blood (2019) 134 (Supplement_1): 993.

https://doi.org/10.1182/blood-2019-129937

Published: 2019

Journal Articles

Spare the Spleen in ALPS: It Is Not an Expendable Vestigial Organ

V. Koneti Rao, MD FRCPA, Elaine Kulm, Susan Price, Sharon Webster, BSN, Les Folio, MD, Gulbu Uzel, MD, David T Teachey, MD

Blood (2018) 132 (Supplement 1): 2435.

https://doi.org/10.1182/blood-2018-99-117394

Published: 2018

Journal Articles

Transfusion Therapy in a Multi-Ethnic Sickle Cell Population Real-World Practice. a Preliminary Data Analysis of Multicentre Survey

Blood (2018) 132 (Supplement 1): 2389.

https://doi.org/10.1182/blood-2018-99-115938

Published: 2018

Journal Articles

Management of Cytopenias in CTLA4 Haploinsufficiency Using Abatacept and Sirolimus

Gulbu Uzel, MD, Djuro Karanovic, MD, Hua Su, PhD, Amy Rump, Anahita Agharahimi, Steven M. Holland, MD, V. Koneti Rao, MD FRCPA

Blood (2018) 132 (Supplement 1): 2409.

https://doi.org/10.1182/blood-2018-99-120185

Published: 2018

Journal Articles

Safety and Efficacy of Dose-Escalation Hydroxyurea Therapy in Infants and Young Children: A Retrospective Cohort Study

Alex George, MD PhD, Jennifer Nguyen Tran, DO

Blood (2018) 132 (Supplement 1): 3658.

https://doi.org/10.1182/blood-2018-99-112586

Published: 2018

Journal Articles

Clinical and Laboratory Benefits of Early Initiation of Hydroxyurea with Pharmacokinetic Guided Dosing for Young Children with Sickle Cell Anemia

Patrick T. McGann, MD, Omar Niss, MD, Min Dong, PhD, Anu Marahatta, PhD, Tomoyuki Mizuno, PhD, Karen Kalinyak, MD, Theodosia A. Kalfa, MD PhD, Punam Malik, MD, Charles T. Quinn, MD, Russell E. Ware, MD PhD, Alexander A. Vinks, PharmD, PhD FCP

Blood (2018) 132 (Supplement 1): 507.

https://doi.org/10.1182/blood-2018-99-112909

Published: 2018

Journal Articles

Consistent Benefit of L-Glutamine Observed across Patients with Low, Medium, and High Number of Crises Reported in the Year Prior to Screening -- Analysis from the Phase 3 Study of L-Glutamine in Sickle Cell Anemia

Yutaka Niihara, MD, Charles William Stark, PharmD, Rafael Razon, MD, Lan T Tran, MPH, Joseph M Becerra, PharmD, Eduard H. Panosyan, MD, Joseph Louis Lasky, MD

Blood (2018) 132 (Supplement 1): 1065.

https://doi.org/10.1182/blood-2018-99-119720

Published: 2018

Journal Articles

Outcome of Initiating Hydroxyurea in Infancy for Patients with Sickle Cell Disease 2011-2018

Ronay Thomas, B.S., Robin Yates Dulman, MD, Angela Lewis, MSN, FNP-BC, CPHON, Bailey Notarangelo, BS, RN, Elizabeth Yang, MD PhD

Blood (2018) 132 (Supplement 1): 4816.

https://doi.org/10.1182/blood-2018-99-114174

Published: 2018

Journal Articles

Predictors of Adverse Outcome in Sickle Cell Disease Patients from Oman

Salam Alkindi, FRCP, BA, MBBChir, Salma AlJadidi, Safa Al Adawi, Anil Pathare, MD PhD FCPS, MBBS

Blood (2018) 132 (Supplement 1): 4915.

https://doi.org/10.1182/blood-2018-99-118304

Published: 2018

Journal Articles

The Effect of Health Care Disparities on Complications and Mortality in Sickle Cell Disease

Stuthi Pavani Perimbeti, MD MPH, Kevin Ye Hou, MD, Sabarina Ramanathan, MD, Adonas Woodard, MD, Daniel Kyung, MD, Qian Wang, MD MPH, Pamela Ann Crilley, DO, Kristine Ward, MD, Michael Styler, MD

Blood (2018) 132 (Supplement 1): 5886.

https://doi.org/10.1182/blood-2018-99-119961

Published: 2018

Journal Articles

Surgical Splenectomy Alters Red Cell Rheology in Patients with Sickle Cell Disease

Celeste K Kanne, BA, Vivien A Sheehan, MD PhD

Blood (2018) 132 (Supplement 1): 1092.

https://doi.org/10.1182/blood-2018-99-117202

Published: 2018

Journal Articles

Novel use Of Hydroxyurea in an African Region with Malaria (NOHARM): a trial for children with sickle cell anemia

Robert O. Opoka, Christopher M. Ndugwa, Teresa S. Latham, Adam Lane, Heather A. Hume, Phillip Kasirye, James S. Hodges, Russell E. Ware, Chandy C. John

Blood (2017) 130 (24): 2585–2593.

https://doi.org/10.1182/blood-2017-06-788935

Published: 2017

Journal Articles

Sequestration Pattern in ITP Liver/Spleen Scan Correlates with the Presence of Anti-Glycoprotein V Antibodies in ITP Patients

Sufia N. Amini, MD, Annemieke Sobels, MSc, Christianne Duchateau, MD, Masja De Haas, MD PhD, Leendert Porcelijn, MD, Roger Schutgens, MD PhD, Jaap Jan Zwaginga, MD PhD, Martin R. Schipperus, MD PhD

Blood (2017) 130 (Supplement 1): 1046.

https://doi.org/10.1182/blood.V130.Suppl_1.1046.1046

Published: 2017

NARROW

Vaso-Occlusive Crises and Costs of Sickle Cell Disease from a Commercial Payer's Perspective

A Standardized Clinical Flow Adhesion Assay of Whole Blood Adhesion to VCAM-1 Predicts Severe SCD Phenotypes in a 2-Yr Prospective Observational Follow-up of the Original Elipsis Cohort

Hydroxyurea Therapy to Prevent Incident Stroke Among Children with Sickle Cell Anaemia in Jamaica: The Extend Trial

Burden of Illness of Sickle Cell Disease in Countries of the Middle East: A Systematic Literature Review

Sickle Cell Disease Burden in North Lebanon

Characteristics of Marijuana Usage in Sickle Cell Patients: A Nationwide Analysis

Barriers and Facilitators to Chronic Red Cell Transfusion Therapy for Children with Sickle Cell Anemia: Results from the Displace Consortium

Splenomegaly in Children with Sickle Cell Anemia Receiving Hydroxyurea in Sub-Saharan Africa

Spare the Spleen in ALPS: It Is Not an Expendable Vestigial Organ

Transfusion Therapy in a Multi-Ethnic Sickle Cell Population Real-World Practice. a Preliminary Data Analysis of Multicentre Survey

Management of Cytopenias in CTLA4 Haploinsufficiency Using Abatacept and Sirolimus

Safety and Efficacy of Dose-Escalation Hydroxyurea Therapy in Infants and Young Children: A Retrospective Cohort Study

Clinical and Laboratory Benefits of Early Initiation of Hydroxyurea with Pharmacokinetic Guided Dosing for Young Children with Sickle Cell Anemia

Consistent Benefit of L-Glutamine Observed across Patients with Low, Medium, and High Number of Crises Reported in the Year Prior to Screening -- Analysis from the Phase 3 Study of L-Glutamine in Sickle Cell Anemia

Outcome of Initiating Hydroxyurea in Infancy for Patients with Sickle Cell Disease 2011-2018

Predictors of Adverse Outcome in Sickle Cell Disease Patients from Oman

The Effect of Health Care Disparities on Complications and Mortality in Sickle Cell Disease

Surgical Splenectomy Alters Red Cell Rheology in Patients with Sickle Cell Disease

Novel use Of Hydroxyurea in an African Region with Malaria (NOHARM): a trial for children with sickle cell anemia

Sequestration Pattern in ITP Liver/Spleen Scan Correlates with the Presence of Anti-Glycoprotein V Antibodies in ITP Patients

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only